NORTH HAVEN, Conn.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, announced interim results of its multicenter, international, prospective study comparing ...
The FDA has granted 510(k) clearance and to Parietex Optimized Composite mesh, a new version of the company’s Parietex Composite mesh for open and laparoscopic ventral hernia repair, according to a ...
NORTH HAVEN, Conn.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results